Cardiovascular Diseases: Therapeutic Potential of SGLT-2 Inhibitors

Cardiovascular Diseases: Therapeutic Potential of SGLT-2 Inhibitors

Cardiovascular diseases (CVD) are a global health concern, affecting millions of patients worldwide and being the leading cause of global morbidity and mortality, thus creating a major public health concern. Sodium/glucose cotransporter 2 (SGLT2) inhibitors have emerged as a promising class of medic...

Full description

Bibliographic Details
Main Authors: Weronika Frąk, Joanna Hajdys, Ewa Radzioch, Magdalena Szlagor, Ewelina Młynarska, Jacek Rysz, Beata Franczyk
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Biomedicines
Subjects:
diabetes mellitus
heart failure
sodium/glucose cotransporter 2 (SGLT2) inhibitors
bexagliflozin
Online Access:https://www.mdpi.com/2227-9059/11/7/2085

Similar Items

Similar Items